lavender glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 1 production 💊 GLP-1 medications are gaining

Dihexa has been found to potently improve cognitive function in animal models of Alzheimer's disease-like mental impairment

Many organs in the body are affected when B12 is low

Front Pharmacol, 2023, 14: 1293130 Jiang X, Stockwell BR, Conrad M

Cyanocobalamin is contraindicated in individuals with Leber's hereditary optic neuropathy

3,* * Based on 95,334 patients with or without type 2 diabetes (T2DM) who filed a prescription for GLP-1based treatment (tirzepatide, semaglutide, or liraglutide) between 2010 and 2023 for any indication

The approval specifically targeted type 2 diabetes management, not weight loss, marking the beginning of GLP-1's clinical presence in American pharmacies